COMP <GO>
LTRN vs CMMB // ENTERPRISE SCALE & MARKET CAP
Lantern Pharma Inc. (NASDAQ) VS. Chemomab Therapeutics Ltd. (NASDAQ) • 15-METRIC TALLY: LTRN 2
— CMMB 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: LTRN
LAST: $0.64 (-3.15%) • MKT CAP: $9.9M
market-cap
$9.9M
LAST: $1.18 (+1.72%) • MKT CAP: $9.3M
market-cap
$9.3M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LTRN VS. CMMB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LTRN | CMMB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | LTRN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.5 | 38.7 | -4.20 | CMMB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $9.9M | $9.3M | $533.0K | LTRN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LTRN REV | CMMB REV | LTRN GROSS % | CMMB GROSS % | LTRN FCF | CMMB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $50.3M | $313.6M | — | — | -$15.7M | -$11.1M |
| FY 2024 | $62.2M | $288.4M | — | — | -$17.8M | -$15.4M |
| FY 2023 | $50.1M | $109.0M | — | — | -$14.3M | -$23.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LTRN // BETA —
CMMB // BETA —